Orexo AB (publ) (LON:0H19)
16.54
+0.61 (3.83%)
At close: Feb 14, 2025
Orexo AB Revenue
In the year 2024, Orexo AB had annual revenue of 590.00M SEK, down -7.64%. Orexo AB had revenue of 160.30M in the quarter ending December 31, 2024, a decrease of -3.43%.
Revenue
590.00M SEK
Revenue Growth
-7.64%
P/S Ratio
n/a
Revenue / Employee
5.36M SEK
Employees
110
Market Cap
43.75M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 590.00M | -48.80M | -7.64% |
Dec 31, 2023 | 638.80M | 14.50M | 2.32% |
Dec 31, 2022 | 624.30M | 59.30M | 10.50% |
Dec 31, 2021 | 565.00M | -98.60M | -14.86% |
Dec 31, 2020 | 663.60M | -181.20M | -21.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
BP p.l.c. | 149.68B |
British American Tobacco p.l.c. | 25.87B |